Cervicovaginal Secretory Antibodies to Human Immunodeficiency Virus Type 1 (HIV-1) that Block Viral Transcytosis through Tight Epithelial Barriers in Highly Exposed HIV-1–Seronegative African Women

Antibodies to human immunodeficiency virus (HIV) of the IgA, IgG, and IgM isotypes and high levels of the HIV suppressive β-chemokine RANTES (regulated on activation, normally T cell expressed and secreted) were found in the cervicovaginal secretions (CVSs) of 7.5% of 342 multiply and repeatedly exp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of infectious diseases 2001-12, Vol.184 (11), p.1412-1422
Hauptverfasser: Bélec, Laurent, Ghys, Peter D., Hocini, Hakim, Nkengasong, John N., Tranchot-Diallo, Juliette, Diallo, Mamadou O., Ettiègne-Traore, Virginie, Maurice, Chantal, Becquart, Pierre, Matta, Mattieu, Si-Mohamed, Ali, Chomont, Nicolas, Coulibaly, Issa-Malick, Wiktor, Stefan Z., Kazatchkine, Michel D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Antibodies to human immunodeficiency virus (HIV) of the IgA, IgG, and IgM isotypes and high levels of the HIV suppressive β-chemokine RANTES (regulated on activation, normally T cell expressed and secreted) were found in the cervicovaginal secretions (CVSs) of 7.5% of 342 multiply and repeatedly exposed African HIV-seronegative female sex workers. The antibodies are part of a local compartmentalized secretory immune response to HIV, since they are present in vaginal fluids that are free of contaminating semen. Cervicovaginal antibodies showed a reproducible pattern of reactivity restricted to gp160 and p24. Locally produced anti-env antibodies exhibit reactivity toward the neutralizing ELDKWA epitope of gp41. Study results show that antibodies purified from CVSs block the transcytosis of cell-associated HIV through a tight epithelial monolayer in vitro. These findings suggest that genital resistance to HIV may involve HIV-specific cervicovaginal antibody responses in a minority of highly exposed HIV-seronegative women in association with other protecting factors, such as local production of HIV-suppressive chemokines
ISSN:0022-1899
1537-6613
DOI:10.1086/324375